Story

Amrize Stock Slides After Q2 Profit Miss, Slashed Outlook on Rising Costs

ENTHMSVIIDZHZH-TWJAKOHI
Aug 7, 20262 min read
Amrize Stock Slides After Q2 Profit Miss, Slashed Outlook on Rising Costs
Text size
Background

Shares of Amrize AG plunged more than 9% in trading after the company's second-quarter profit fell short of Wall Street expectations and it lowered its full-year adjusted EBITDA forecast, pointing to the impact of rising oil-related costs.

Q2 Results Disappoint on Profitability

While Amrize reported a top-line beat, investors focused on the company's weaker-than-expected profitability. The results for the second quarter of 2026 revealed a mix of strong sales and pressured margins.

  • Earnings Per Share (EPS): $0.88, missing the analyst consensus of $0.96.
  • Revenue: $3.5 billion, exceeding the $3.35 billion estimate, marking a 6.7% year-over-year organic increase.
  • Adjusted EBITDA: Rose 5.8% to $986 million.

Despite the revenue growth, the bottom-line miss was a significant factor in the negative market reaction, according to the company's Q2 2026 report.

Guidance Cut Signals Margin Pressure

Sample IUX Markets – In-articleAd

The most significant driver of the sell-off was the downward revision to the company's full-year outlook. Amrize slashed its forecast for adjusted EBITDA, attributing the change directly to higher input costs stemming from elevated oil prices.

This forward-looking signal suggests that margin pressures are proving more persistent than the company had previously anticipated. The guidance cut landed particularly hard with investors, as some analysts had already been trimming their price targets on the stock in recent weeks amid cautious reassessments of the cost environment.

Market Impact

The combination of an earnings miss and a reduced forecast triggered a decisive sell-off, sending the stock down 9.1% to 38 per share, approaching its 52-week low of 37.32. The move was company-specific, as broader U.S. equity indexes traded within a narrow range during the session.

Investors are now reassessing the company's ability to restore margin expansion in a higher-cost operating environment. While industry peers also face similar input cost challenges, Amrize's guidance cut has put its specific situation in the spotlight.

Read next

More on Stocks
Back to latest news

LATEST